HER-2/ neu overexpression was estimated by immunohistochemistry (IHC) using the Hercep test (DAKO). An IHC score of 2+ or greater was considered positive. Overall survival was calculated from the date of diagnosis of lung carcinoma by the Kaplan–Meier product limit method. Fourteen non-...
Univariate analysis showed that histological type, histologic grade and pathologic stage (pT) were not correlated with the RFS rate. Patients with node-positive (pN+) TNBC were more likely to relapse, although this trend did not reach significance (P = 0.056). Analysis of whether the HER...
Ms. J is a 55-year-old woman who was diagnosed with stage IIIA colon cancer three months ago. Prior to her diagnosis, she experienced an unintentional 17-pound weight loss. She underwent an exploratory laparotomy with colon resection. Following recovery from her surgery, she began an adjuvant...
新辅助化疗前后乳腺 癌灶组织(化疗前麦默通空心针活检组织和根治性手术后大体标本病灶组织)均 应用免疫组化Envision 二步法检测生物标记物(ER、PR、HER-2、EGFR 及CK5/6 ) 的表达。结果:7例达病理完全缓解(pCR)术后不能进行免疫组化检测,75 例新 辅助化疗前后 ER、 PR、 HER-2 发生量变的分别有 17、10、...
收集国内外关于H E R -2在H C C 中表达的病例-对照研究,检索时限为从建库至2023年5月㊂由2名研究者独立检索筛选文献㊁提取资料并评价偏倚风险,用R e v m a n 5.3软件进行m e t a 分析㊂结果 最终纳入31个病例-对照研究,共计2558例患者㊂M e t a 分析结果显示:H E R -2在H C C 中...
On October 8, Fischer announced she had been diagnosed with Stage 1 Triple Positive Breast Cancer — but followed up the announcement with some excellent news: She had finished chemotherapy and is now cancer-free. On October 21, Fischer joined TODAY and spoke extensively of her thought process,...
The study patients were selected from the pooled database according to the following criteria: unilateral stage pT1 – 3, N0 – 1, M0, HER-2-positive invasive breast carcinoma diagnosed between 1984 and 2006, no neoadjuvant chemotherapy and surgical treatment with either breast-conserving therapy...
需要金币:*** 金币(10金币=人民币1元) 乳腺癌腋窝淋巴结中ER、PR、HER-2表达及Ⅲ区淋巴结与预后相关因素的研究.pdf 关闭预览 想预览更多内容,点击免费在线预览全文 免费在线预览全文 乳腺癌腋窝淋巴结中ER、PR、HER-2表达及Ⅲ区淋巴结与预后相关因素的研究 ...
HER-2阳性乳腺癌治疗的进展 江苏省肿瘤医院 肿瘤内科 Her-2 检测的进展 肿瘤学临床实践指南 (NCCN指南®):乳腺癌。 版本1.2021。 2021年1月15日。 可在:www.NCCN.org。 于2021年1月 22日查阅。 HER2测试指南更新:2018年 ▪ 2018年对ASCO/CAP准则的更新认可了2013年准则,同时解决了悬而 未决的问题: ...
breakthroughshavebeenmadeintheresearchandclinicalapplicationoftumortargetedtherapy.TheHER-2genehasimportantguidingvalueinthediagnosis,treatmentandevaluationofprognosisofbreastcancer.Thisarticlereviewstheanti-HER-2targetingdrugsandindividualizedtreatmentofHER-2positivebreastcancerpatients.Keywords:Breastcancer;HER-2;Targeted...